Treatment of osteoporosis after liver transplantation with ibandronate

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Transplant International

• Publication date

  2010-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1432-2277.2010.01061.xPMID 20158691
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Long-Acting Isosorbide Mononitrate

  2012cited by this paper
• Post-transplantation Osteoporosis

  2011cited by this paper
• Post-transplantation osteoporosis.

  2010cited by this paper
• Bisphosphonates and Bone Fractures in Long-term Kidney Transplant Recipients

  2008cited by this paper
• Alendronate once weekly for the prevention and treatment of bone loss in Canadian adult cystic fibrosis patients (CFOS trial).

  2008cited by this paper
• Quality of life up to 30 years following liver transplantation

  2008cited by this paper
• Preclinical evidence for nitrogen-containing bisphosphonate inhibition of farnesyl diphosphate (FPP) synthase in the kidney: implications for renal safety.

  2008cited by this paper
• Determinants of bone mass in end‐stage renal failure patients at the time of kidney transplantation

  2008cited by this paper
• Prophylactic Bisphosphonate Treatment Prevents Bone Fractures After Liver Transplantation

  2007cited by this paper
• Impaired Bone Health in Adolescents After Liver Transplantation

  2007cited by this paper
• Zoledronic Acid Prevents Bone Loss after Liver Transplantation

  2006cited by this paper
• Summaries for patients. Zolendronic acid prevents bone loss after liver transplantation.

  2006cited by this paper
• Bone mineral density before and after OLT: Long‐term follow‐up and predictive factors

  2006cited by this paper
• Pamidronate and osteoporosis prevention in liver transplant recipients

  2006cited by this paper
• A Controlled Study of Vitamin D3 to Prevent Bone Loss in Renal-Transplant Patients Receiving Low Doses of Steroids

  2005cited by this paper
• Alendronate in combination with calcium and vitamin D prevents bone loss after orthotopic liver transplantation: A prospective single‐center study

  2005cited by this paper
• [Osteoporosis associated with chronic liver disease].

  2004influential reference
• [Importance of biochemical indicators of bone turnover in patients on chronic dialysis and after kidney transplantation].

  2004cited by this paper
• Health-related quality of life and radiographic vertebral fracture

  2004cited by this paper
• Bad to the bone: the effects of liver diseases on bone.

  2004cited by this paper
• Metabolic bone disease in patients with liver disease

  2003influential reference
• Low bone mineral density in noncholestatic liver cirrhosis: prevalence, severity and prediction.

  2003cited by this paper
• Three-monthly ibandronate bolus injection offers favourable tolerability and sustained efficacy advantage over two years in established corticosteroid-induced osteoporosis.

  2003cited by this paper
• Serum osteoprotegerin is a major determinant of bone density development and prevalent vertebral fracture status following cardiac transplantation.

  2003cited by this paper
• Intermittent intravenous ibandronate injections reduce vertebral fracture risk in corticosteroid-induced osteoporosis: results from a long-term comparative study

  2003cited by this paper
• Secondary Osteoporosis in Liver Transplant Recipients: a Longitudinal Study in Patients With and Without Cholestatic Liver Disease

  2003cited by this paper
• Osteoporosis after liver transplantation

  2003cited by this paper
• Effect of transplantation on bone: osteoporosis after liver and multivisceral transplantation.

  2002cited by this paper
• Labordiagnostik der Osteoporose

  2001cited by this paper
• Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation: a follow-up study.

  2001cited by this paper
• High Prevalence of Osteoporosis in Patients with Chronic Liver Disease Prior to Liver Transplantation

  2001cited by this paper
• [Laboratory diagnosis of osteoporosis].

  2001cited by this paper
• Sind Crosslinks klinisch aussagekräftige Osteoporosemarker? Evaluation in einem Bevölkerungsquerschnitt

  2001cited by this paper
• Intravenous Pamidronate as Treatment for Osteoporosis after Heart Transplantation: A Prospective Study

  2001cited by this paper
• [Clinical value of urinary pyridinium crosslinks as osteoporosis markers: evaluation of a population survey of vertebral osteoporosis].

  2001cited by this paper
• Laboratory methods to diagnose osteoporosis

  2001cited by this paper
• [Bone metabolism as assessed with selected markers of bone turnover as well as densitometry analysis in patients after successful kidney transplantation].

  2001cited by this paper
• Transplantation osteoporosis and corticosteroid-induced osteoporosis in autoimmune diseases: experience with alfacalcidol

  2000cited by this paper
• Magnetic resonance imaging (MRI) controlled outcome of side effects caused by ionizing radiation, treated with 780 nm-diode laser -- preliminary results.

  2000cited by this paper
• Bone density and metabolism in patients with viral hepatitis and cholestatic liver diseases before and after liver transplantation

  2000cited by this paper
• [Osteoporosis in rheumatoid arthritis--significance of alfacalcidol in prevention and therapy].

  2000cited by this paper
• Serum CTX: A New Marker of Bone Resorption That Shows Treatment Effect More Often Than Other Markers Because of Low Coefficient of Variability and Large Changes with Bisphosphonate Therapy

  2000cited by this paper
• Osteoporose bei rheumatoider Arthritis – Bedeutung von Alfacalcidol in Prävention und Therapie

  2000cited by this paper
• Incidence of vertebral fractures in the first three months after orthotopic liver transplantation

  2000cited by this paper
• Ibandronate.

  1999cited by this paper
• [Post-transplantation osteoporosis].

  1999cited by this paper
• Osteoporosis after organ transplantation.

  1998cited by this paper
• Intravenous bisphosphonate prevents symptomatic osteoporotic vertebral collapse in patients after liver transplantation.

  1998cited by this paper
• Prevention of bone loss after heart transplantation with antiresorptive therapy: a pilot study.

  1998cited by this paper
• Fractures Attributable to Osteoporosis: Report from the National Osteoporosis Foundation

  1997cited by this paper
• Administration of the bisphosphonate ibandronate (BM 21.0955) by intravenous bolus injection

  1996cited by this paper
• Bone loss after heart transplantation: a prospective study.

  1994cited by this paper
• Corticosteroid-induced osteoporosis.

  1994cited by this paper
• Bisphosphonates act on rat bone resorption through the mediation of osteoblasts.

  1993cited by this paper
• Corticosteroid-induced osteoporosis.

  1993cited by this paper

• Vertebral fracture incidence and risk factors following liver transplantation: tertiary transplant center experience

  2025cites this paper
• A scoping review on the efficacy, effectiveness, and safety of different antiresorptives for the management of patients with secondary osteoporosis due to transplants

  2025cites this paper
• S2k-Leitlinie Lebertransplantation der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV)

  2024cites this paper
• Evaluation of Bone Mineral Density in Lung Transplant Recipients by Chest Computed Tomography

  2023cites this paper
• The effect of zoledronic acid on hip geometry in renal transplant recipients: a double-blind placebo-controlled randomized study

  2023cites this paper
• Impact of Liver Cirrhosis on Bone Metabolism

  2022cites this paper
• Secondary Osteoporosis.

  2021cites this paper
• Bisphosphonate therapy after liver transplant improves bone mineral density and reduces fracture rates: an updated systematic review and meta‐analysis

  2021cites this paper
• Osteoporosis in organ transplant patients

  2021cites this paper
• Glucocorticoid- and Transplantation-Induced Osteoporosis.

  2021cites this paper
• Analysis of Risk Factors Affecting Incidence of Osteoporosis and Fragility Fractures in Liver Transplant Recipients

  2020cites this paper
• Transplantation Osteoporosis

  2020cites this paper
• Bone disease following solid organ transplantation: A narrative review and recommendations for management from The European Calcified Tissue Society.

  2019cites this paper
• Transplantationsosteoporose: Knochenstoffwechselstörung nach Organtransplantation

  2018cites this paper
• Osteoporosis in Organ Transplant Patients

  2016cites this paper
• Chapter 37 – Nutritional Aspects of Transplantation in Adults

  2015cites this paper
• Osteoporosis treatment: why ibandronic acid?

  2013cites this paper
• 61. Transplantation Osteoporosis

  2013cites this paper
• Osteoporose nach Herztransplantation

  2012cites this paper
• Nutritional interventions for liver-transplanted patients.

  2012cites this paper
• Bone Disease After Organ Transplantation with Special Regard of Post Transplantation-Osteoporosis After Liver Transplantation

  2012cites this paper
• Monthly ibandronate for the prevention of bone loss in patients after liver transplantation.

  2012cites this paper
• Treatment of bone loss in patients with chronic liver disease awaiting liver transplantation

  2012cites this paper
• Geneesmiddelen ter preventie van osteoporosische fracturen

  2011cites this paper
• Medical management of the liver transplant recipient.

  2011cites this paper
• Prevention of fractures after solid organ transplantation: a meta-analysis.

  2011influential citation
• Effect of early risedronate treatment on bone mineral density and bone turnover markers after liver transplantation: a prospective single‐center study

  2011cites this paper
• The role of i.v. ibandronate administration in osteoporosis therapy.

  2011cites this paper
• Fracture incidence after liver transplantation: results of a 10 year audit

  2011cites this paper
• Bone disease in patients with primary sclerosing cholangitis.

  2011cites this paper
• Long-Term Management of the Liver Transplant Patient

  2011cites this paper
• The Characteristics and Treatment of Bone Loss after Liver Transplant

  2011influential citation
• Lebererkrankungen und Osteoporose

  2011cites this paper